RR

Rajasekhar Reddy Gopu

Active Director Director DIN 10646707
DIN 10646707 First appointment May 2024 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajasekhar Reddy Gopu

Data last updated:

Rajasekhar Reddy Gopu is a Director at Tibro Pharmaceuticals Private Limited (since 2024). The company operates in Chemicals and Materials.

DIN 10646707
Primary Designation Director
Industry Chemicals and Materials
First Appointment 29 May 2024
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 May 20242020Active

Directorship timeline

Open interactive timeline →
Tibro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajasekhar Reddy Gopu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajasekhar Reddy Gopu

Rajasekhar Reddy Gopu currently holds 1 directorship: Tibro Pharmaceuticals Private Limited (Director, since 29 May 2024).

Rajasekhar Reddy Gopu was first appointed on 29 May 2024 as Director at Tibro Pharmaceuticals Private Limited.

The current boards of Rajasekhar Reddy Gopu's companies include Kasi Viswanadharaju Pericherla (Tibro Pharmaceuticals Private Limited), Pericherla Venkata Subba Raju (Tibro Pharmaceuticals Private Limited), Venkata Subramanyam Raju Penmetsa (Tibro Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available